Discover Oncology (Mar 2022)
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
- Keita Sasa,
- Tsuyoshi Saito,
- Taisei Kurihara,
- Nobuhiko Hasegawa,
- Kei Sano,
- Daisuke Kubota,
- Keisuke Akaike,
- Taketo Okubo,
- Takuo Hayashi,
- Tatsuya Takagi,
- Takashi Yao,
- Muneaki Ishijima,
- Yoshiyuki Suehara
Affiliations
- Keita Sasa
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Tsuyoshi Saito
- Department of Human Pathology, Juntendo University School of Medicine
- Taisei Kurihara
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Nobuhiko Hasegawa
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Kei Sano
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Daisuke Kubota
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Keisuke Akaike
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Taketo Okubo
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Takuo Hayashi
- Department of Human Pathology, Juntendo University School of Medicine
- Tatsuya Takagi
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Takashi Yao
- Department of Human Pathology, Juntendo University School of Medicine
- Muneaki Ishijima
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- Yoshiyuki Suehara
- Department of Medicine for Orthopaedics and Motor Organ, Juntendo University School of Medicine
- DOI
- https://doi.org/10.1007/s12672-022-00481-6
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
